Breakthrough trial tests Chemo-Free approach for blood cancer
NCT ID NCT02666898
Summary
This study tested a chemotherapy-free treatment approach for adults with previously untreated chronic lymphocytic leukemia (CLL), a type of blood cancer. All 135 participants received two targeted drugs (obinutuzumab and ibrutinib) for nine months. After this initial treatment, doctors measured remaining cancer levels and adjusted further treatment based on those results, aiming for better disease control with fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sponsor FILO
Tours, 37054, France
Conditions
Explore the condition pages connected to this study.